Pediatrics: Neuroprotective effects of erythropoietin in preterm infants

Nature Reviews Neurology

Volumn 6, Issue 6, 2010, Pages 301-302

  Limperopoulos, Catherine ^a  

^a MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; RECOMBINANT ERYTHROPOIETIN;

BRAIN HEMORRHAGE; BRAIN INJURY; CEREBRAL PALSY; COGNITIVE DEFECT; DRUG INDICATION; DRUG MECHANISM; HUMAN; INFANT; NERVE CELL DIFFERENTIATION; NEUROPROTECTION; NONHUMAN; PREMATURITY; PRIORITY JOURNAL; SENSORY DYSFUNCTION; SHORT SURVEY; TREATMENT OUTCOME;

BRAIN DISEASES; CHILD DEVELOPMENT; ERYTHROPOIETIN; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; NEUROPROTECTIVE AGENTS;

EID: 77954835889     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2010.66     Document Type: Short Survey

References (10)

1. Mikkola, K. et al. neurodevelopmental outcome at 5 years of age of a national cohort of extremely low birth weight infants who were born in 1996-1997. Pediatrics 116, 1391-1400 (2005).
2. Gonzalez, F. F. et al. erythropoietin enhances long-term neuroprotection and neurogenesis in neonatal stroke. Dev. Neurosci. 29, 321-330 (2007).
3. Juul, s. e. et al. Recombinant erythropoietin is neuroprotective in a novel mouse oxidative injury model. Dev. Neurosci. 30, 231-242 (2008).
4. siren, A. L., Fasshauer, T., Bartels, C. & ehrenreich, H. Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system. Neurotherapeutics 6, 108-127 (2009).
5. neubauer, A. P., voss, W., wachtendorf, M. & Jungmann, T. erythropoietin improves neurodevelopmental outcome of extremely preterm infants. Ann. Neurol. doi: 10.1002/ ana.21977.
6. sola, A., wen, T. C., Hamrick, s. e. & Ferriero, D. M. Potential for protection and repair following injury to the developing brain: a role for erythropoietin? Pediatr. Res. 57, R110-R117 (2005).
7. Bierer, R., Peceny, M. C., Hartenberger, C. H. & Ohls, R. K. erythropoietin concentrations and neurodevelopmental outcome in preterm infants. Pediatrics 118, e635-e640 (2006).
8. Brown, M. s., eichorst, D., Lala-Black, B. & Gonzalez, R. Higher cumulative doses of erythropoietin and developmental outcomes in preterm infants. Pediatrics 124, e681-e687 (2009).
9. newton, n. R., Leonard, C. H., Piecuch, R. e. & Phibbs, R. H. neurodevelopmental outcome of prematurely born children treated with recombinant human erythropoietin in infancy. J. Perinatol. 19, 403-406 (1999).
10. Ohls, R. K. et al. neurodevelopmental outcome and growth at 18 to 22 months' corrected age in extremely low birth weight infants treated with early erythropoietin and iron. Pediatrics 114, 1287-1291 (2004).